Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (301-310 of 1,280) with videos related to

Pageof 128
Sort By:
Journal of Medical Virology|November 1, 1988
Epidemiology of delta infection in SpainM Buti, R Esteban, R Jardi, et al.
Liver|April 1, 1986
Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitisJ Guardia, R Esteban, M Buti, et al.
Journal of Cancer Research and Therapeutics|February 17, 2016
Very late recurrence of an apparently benign pheochromocytomaElena Thai, Letizia Gnetti, Annalisa Gilli, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2017
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasmsJavier Crespo, Rafael Esteban, Covadonga Torres, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 1, 2022
Improved healthy tissue sparing in proton therapy of lung tumors using statistically sound robust optimization and evaluationVlad Badiu, Kevin Souris, Gregory Buti, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2003
Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferonR San Miguel, J Mar, J M Cabasés, et al.
The Journal of General Virology|November 21, 2001
Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitisSonia Pina, Maria Buti, Rosend Jardí, et al.
Immunotherapy|November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysisSebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.
Physics in Medicine and Biology|July 8, 2021
Introducing a probabilistic definition of the target in a robust treatment planning frameworkGregory Buti, Kevin Souris, Ana Maria Barragán Montero, et al.
Expert Review of Molecular Diagnostics|October 15, 2019
Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic reviewSara Elena Rebuzzi, Fabiana Perrone, Melissa Bersanelli, et al.
Pageof 128

Showing results (301-310 of 1,280) with videos related to

Sort By:
Pageof 128
Journal of Medical Virology|November 1, 1988
Epidemiology of delta infection in SpainM Buti, R Esteban, R Jardi, et al.
Liver|April 1, 1986
Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitisJ Guardia, R Esteban, M Buti, et al.
Journal of Cancer Research and Therapeutics|February 17, 2016
Very late recurrence of an apparently benign pheochromocytomaElena Thai, Letizia Gnetti, Annalisa Gilli, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2017
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasmsJavier Crespo, Rafael Esteban, Covadonga Torres, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 1, 2022
Improved healthy tissue sparing in proton therapy of lung tumors using statistically sound robust optimization and evaluationVlad Badiu, Kevin Souris, Gregory Buti, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2003
Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferonR San Miguel, J Mar, J M Cabasés, et al.
The Journal of General Virology|November 21, 2001
Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitisSonia Pina, Maria Buti, Rosend Jardí, et al.
Immunotherapy|November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysisSebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.
Physics in Medicine and Biology|July 8, 2021
Introducing a probabilistic definition of the target in a robust treatment planning frameworkGregory Buti, Kevin Souris, Ana Maria Barragán Montero, et al.
Expert Review of Molecular Diagnostics|October 15, 2019
Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic reviewSara Elena Rebuzzi, Fabiana Perrone, Melissa Bersanelli, et al.
Pageof 128